MALIGNANT SOLID TUMOR
Clinical trials for MALIGNANT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT SOLID TUMOR trials appear
Sign up with your email to follow new studies for MALIGNANT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Time immune boost targets Hard-to-Treat stomach cancers
Disease control Not yet recruitingThis early-phase study tests whether a single dose of two immunotherapy drugs can increase cancer-fighting immune cells inside tumors. It includes 34 adults with untreated stomach or esophageal cancers that have not spread and carry a specific gene change called ARID1A. The goal …
Matched conditions: MALIGNANT SOLID TUMOR
Phase: EARLY_PHASE1 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New hope for brain metastases: drug combo targets tumors in the brain
Disease control Not yet recruitingThis study tests a combination of two drugs (utidelone and bevacizumab), with or without a third (etoposide), in 56 people whose cancer has spread to the brain. The goal is to see if this treatment can shrink brain tumors and improve outcomes. Participants have lung or breast can…
Matched conditions: MALIGNANT SOLID TUMOR
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 08, 2026 12:03 UTC